Bliss Gvs Pharma Cash Flow Annual

Trade
BSE: 506197 | NSE: BLISSGVS | ISIN: INE416D01022 | Sector: Biotechnology & Drugs
132.25 +0.75 (0.57%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 146.07106.07127.76104.13
Depreciation/ Depletion 26.3818.6717.3317.23
Non- Cash Items 11.8139.24-49.0429.06
Changesin Working Capital -31.81-129.6739.43-86.45
Cashfrom Operating Activities 152.4534.31135.4863.97
Capital Expenditures -28.33-93.80-74.00-9.12
Other Investing Cash Flow Items Total -104.4986.05-18.97-37.87
Cashfrom Investing Activities -132.82-7.75-92.98-46.99
Financing Cash Flow Items -6.06-6.30-2.96-6.32
Total Cash Dividends Paid -5.39-5.44-5.33-5.55
Issuance( Retirement)of Stock Net 2.312.042.28-
Issuance( Retirement)of Debt Net -11.75-15.25-17.73-8.93
Cashfrom Financing Activities -20.89-24.94-23.73-20.80
Foreign Exchange Effects -0.151.40-9.921.61
Net Changein Cash -1.423.028.85-2.21
Cash Interest Paid 6.106.302.966.32
Cash Taxes Paid 34.8544.5633.9428.56
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts